Why Ozempic Doesn’t Work for Everyone: Scientists Just Found a Hidden Reason

Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason

A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about 10% of people due to specific genetic variants. These individuals appear to have a puzzling condition called “GLP-1 resistance,” where their bodies produce higher levels of the hormone targeted by these drugs—but don’t respond to it properly.

New Study Finds Genetic Variants May Limit Ozempic Results

GLP-1 style drugs like Ozempic and Wegovy have become a gamechanger in the fight against type 2 diabetes and lowering body fat, but for a significant portion of the population, the drugs have proved to be less successful. This could be attributed to specific resistance to GLP-1s, suggests some startling new science. New Stanford Research Links Genetics to Ozempic and Wegovy Response The new research, coming out of Stanford, and involving teams f…